Storia in 2 fonti

Appeals court revives $6.7B lawsuit against Bristol Myers Squibb

A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment

Raccontata da

qz.com

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

qz.comStai leggendo2 g fa

Appeals court revives $6.7B lawsuit against Bristol Myers Squibb

A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment

originale

fiercepharma.com1 g fa

It's BMS vs. Celgene investors once more after US appeals court revives lawsuit

A federal appeals court has overturned (PDF) the 2024 dismissal of a lawsuit filed by Celgene shareholders that accuses Bris | A U.S. appeals court has revived a lawsuit filed by Celgene shareholders that accuses…

Leggi questa versione → originale

Timeline cronologica

giovedì 13 agosto 2026·qz.com
Appeals court revives $6.7B lawsuit against Bristol Myers Squibb
A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment
venerdì 14 agosto 2026·fiercepharma.com
It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
A federal appeals court has overturned (PDF) the 2024 dismissal of a lawsuit filed by Celgene shareholders that accuses Bris | A U.S. appeals court has revived a lawsuit filed by…